🔎 Trials Near Me

Akèy › Maladi otoim › Ohio

Etid klinik pou Maladi otoim nan Ohio

13 etid pou Maladi otoim ap chèche patisipan nan sit nan Ohio.

Vil nan Ohio

Tèks ofisyèl etid la (Anglè)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Ohio State University Comprehensive Cancer Center, Columbus
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

  • Cleveland Clinic Foundation, Cleveland
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 21, 2026 · NCT07513181

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Cleveland Clinic, Cleveland
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Cleveland Clinic, Cleveland
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318

Abatacept for the Treatment of Giant Cell Arteritis

  • Cleveland Clinic, Cleveland
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT04474847

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Cleveland Clinic, Cleveland
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT06056297

Study of BHV-1300 in Graves' Disease

  • Site-110, Canton
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jul 31, 2026 · NCT06980649

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1038, Cincinnati
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Jul 30, 2026 · NCT07039916

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Childrens Hospital Medical Center of Akron, Akron
  • Cincinnati Children's Hospital, Cincinnati
  • University Hospitals Case Medical Center, Cleveland
  • ak 3 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • MetroHealth, Cleveland
Ap rekriteFaz 1
Laj 12 a 70 · Tout sèks · Mizajou May 22, 2026 · NCT06308978

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

  • Ohio State University, Columbus
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT06626919

Central Vein Sign in Multiple Sclerosis Extension Study

  • Cleveland Clinic Foundation, Cleveland
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Feb 20, 2026 · NCT07424027

IMPACT - AndHealth Autoimmune Research Registry

  • AndHealth, Columbus
Ap rekriteEtid obsèvasyon
Laj 18 a 70 · Tout sèks · Mizajou Jun 29, 2023 · NCT05883371

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.